MedTrace Logo

Omics Profiling of Weight Loss With Bariatric Surgery

NCT02757638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-09-30

No results posted yet for this study

Summary

Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by bariatric surgery procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.

Conditions

Interventions

OTHER

Stable isotope infusion

such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline

Sponsors & Collaborators

Principal Investigators

  • Marielle Engelen, PhD · Texas A&M University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-25
Primary Completion
2018-06-29
Completion
2018-06-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757638 on ClinicalTrials.gov